Trademarkia Logo

Canada

C$
IDEA TO CLINIC
FORMALIZED

on 22 Jan 2025

Last Applicant/ Owned by

National Resilience, Inc.

3115 Merryfield Row, Suite 200San Diego, CA 92121

US

Serial Number

2375609 filed on 22nd Jan 2025

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

IDEA TO CLINIC

Trademark usage description

custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, Read More

Classification Information


Class [040]
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platform for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology


Classification kind code

12

Class [042]
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; design and development of technology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; provision of information relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services relating to the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; preparation of reports relating to biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins


Classification kind code

12

Mark Details


Serial Number

2375609

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 135
on 11th Feb 2025
Amendment to Application
Submitted for opposition 287
on 6th Feb 2025
Pre-Assessment Letter Sent
Submitted for opposition 30
on 22nd Jan 2025
Filed
Submitted for opposition 1
on 22nd Jan 2025
Created
Submitted for opposition 31
on 22nd Jan 2025
Formalized